Christelle Parent
Tours, 37032, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Exploring airway biological barriers: Implications for IgG-based therapeutics in respiratory infections.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: March 06, 2025
Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa.
Journal: Molecular therapy. Methods & clinical development
Published: December 14, 2023
The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: October 18, 2023
Description of a Murine Model of Pneumocystis Pneumonia.
Journal: Mycopathologia
Published: October 10, 2023
Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection.
Journal: Mucosal immunology
Published: December 30, 2022
Cleavage of Occludin by Cigarette Smoke-Elicited Cathepsin S Increases Permeability of Lung Epithelial Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: November 09, 2022
Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis.
Journal: British journal of pharmacology
Published: October 01, 2020
Exploring the fate of inhaled monoclonal antibody in the lung parenchyma by microdialysis.
Journal: mAbs
Published: February 05, 2019
In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 17, 2019
Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model.
Journal: Frontiers in microbiology
Published: November 19, 2018
Last Updated: 09/26/2026